Medinotec (MDNC) Depreciation & Amortization (CF) (2022 - 2026)
Medinotec (MDNC) posted Depreciation & Amortization (CF) of $21282.0 for Q2 2026, down 63.44% on a QoQ basis from $58204.0 in Q1 2026, and up 183.53% year-over-year from $7506.0 in Q2 2025.
Medinotec (MDNC) Depreciation & Amortization (CF) (2022 - 2026) Analysis & Trends
Medinotec's Depreciation & Amortization (CF) history runs 5 years deep, the most recent figure standing at $21282.0 for Q2 2026.
- Quarterly Depreciation & Amortization (CF) rose 183.53% year-over-year to $21282.0 in Q2 2026, while the trailing twelve-month figure through May 2026 was $94649.0 (up 62.84% YoY) and the FY2026 annual result came in at $80873.0, up 9.52% from the prior year.
- Depreciation & Amortization (CF) was $21282.0 for Q2 2026 at Medinotec, down from $58204.0 in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $82809.0 in Q1 2022 and bottomed at -$10600.0 in Q1 2023.
- A 5-year average of $22254.9 and a median of $20545.5 in 2022 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2023 — Depreciation & Amortization (CF) slumped 112.8% — and 2026, when it soared 8959.06%.
- Medinotec's Depreciation & Amortization (CF) stood at $19809.0 in 2022, then retreated by 12.18% to $17396.0 in 2023, then surged by 49.26% to $25966.0 in 2024, then sank by 70.48% to $7666.0 in 2025, then surged by 177.62% to $21282.0 in 2026.
- Business Quant data shows MDNC's Depreciation & Amortization (CF) at $21282.0 in Q2 2026, $58204.0 in Q1 2026, and $7666.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 67.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 310.25 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Medinotec | 58.78 Mn | 58.19 Mn | 1.31 Mn | 21,282.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 21,282.00 |
| May 31, 2026 | 21,282.00 |
| Feb 28, 2026 | 58,204.00 |
| Feb 28, 2026 | 58,204.00 |
| Nov 30, 2025 | 7,666.00 |
| Nov 30, 2025 | 7,666.00 |
| Aug 31, 2025 | 7,497.00 |
| Aug 31, 2025 | 7,497.00 |
| May 31, 2025 | 7,506.00 |
| May 31, 2025 | 7,506.00 |
| Feb 28, 2025 | -657.00 |
| Feb 28, 2025 | -657.00 |
| Nov 30, 2024 | 25,966.00 |
| Nov 30, 2024 | 25,966.00 |
| Aug 31, 2024 | 25,309.00 |
| Aug 31, 2024 | 25,309.00 |
| May 31, 2024 | 23,228.00 |
| May 31, 2024 | 23,228.00 |
| Feb 29, 2024 | 33,561.00 |
| Feb 29, 2024 | 33,561.00 |